A recent study published on June 8, 2026, highlights a new drug that may functionally cure a substantial number of hepatitis B virus infections.
This development could represent a major advancement in the fight against hepatitis B, a virus that affects millions globally.
While the findings are promising, further research will be necessary to fully understand the drug's efficacy and long-term implications.